Home

PLUS THERAPEUTICS, Inc. - Common Stock (PSTV)

0.5327
+0.0443 (9.07%)
NASDAQ · Last Trade: Nov 23rd, 2:31 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Signal Advance (OTC: SIGL) Analog Guard® Delivers Maximum Protection Against Quantum-Computing Cyber Threats
Signal Advance, Inc . (OTC: SIGL ) announced a major leap forward in next-generation cybersecurity as its patented Analog Guard® platform positions the company as a first mover in physics-based, quantum-resistant encryption .
Via AB Newswire · November 20, 2025
D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq:PSTV) in Connection with its up to $15.0 Million Private Placement
HOUSTON, TX / ACCESS Newswire / March 11, 2025 / On March 4th, Plus Therapeutics, Inc. (Nasdaq:PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announced the pricing of a private placement with gross proceeds to the Company expected to be approximately $15.0 million.
Via ACCESS Newswire · March 11, 2025